HC Wainwright Trims Aclaris Therapeutics (NASDAQ:ACRS) Target Price to $9.00
Aclaris Therapeutics (NASDAQ:ACRS – Free Report) had its target price decreased by HC Wainwright from $43.00 to $9.00 in a research report sent to investors on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Aclaris Therapeutics’ Q4 2023 earnings at ($0.50) EPS, […]
More Stories
Sumco (OTCMKTS:SUOPY) Shares Up 0.4% – Time to Buy?
Sumco Co. (OTCMKTS:SUOPY – Get Free Report) rose 0.4% during trading on Thursday . The stock traded as high as...
Wishbone Gold (LON:WSBN) Shares Down 4.2% – Should You Sell?
Wishbone Gold Plc (LON:WSBN – Get Free Report)’s stock price fell 4.2% during trading on Thursday . The company traded...
River and Mercantile UK Micro Cap (LON:RMMC) Stock Price Down 1.2% – Here’s What Happened
River and Mercantile UK Micro Cap (LON:RMMC – Get Free Report)’s stock price was down 1.2% during trading on Thursday...
SEGRO (OTCMKTS:SEGXF) Shares Down 2.9% – What’s Next?
Shares of SEGRO Plc (OTCMKTS:SEGXF – Get Free Report) traded down 2.9% during trading on Thursday . The company traded...
Big Rock Brewery (OTCMKTS:BRBMF) Stock Price Down 3.4% – What’s Next?
Big Rock Brewery Inc. (OTCMKTS:BRBMF – Get Free Report) was down 3.4% during trading on Thursday . The stock traded...
Autozi Internet Technology (Global) (NASDAQ:AZI) and Driven Brands (NASDAQ:DRVN) Head to Head Survey
Autozi Internet Technology (Global) (NASDAQ:AZI – Get Free Report) and Driven Brands (NASDAQ:DRVN – Get Free Report) are both auto/tires/trucks...